The World Market for Cancer Diagnostics, 2024-2029

    Published: January 13, 2025 | Price: $5,000.00 – $10,500.00

    The landscape of cancer diagnostics is evolving with molecular and protein biomarkers indispensable for accurate diagnosis, therapy selection, monitoring treatment response, and early detection of cancer recurrence. Kalorama Information’s The World Market for Cancer Diagnostics, 2024-2029 delivers an authoritative and comprehensive analysis of the global cancer in vitro diagnostics (IVD) market, including industry-defining trends, market sizing, and growth opportunities. This report offers an in-depth review of the cancer IVD market, including expert insights into significant segment markets: Oncology molecular assays...
    In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029

    Published: November 25, 2024 | Price: $5,000.00 – $10,500.00

    The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future. This report is essential for: Identifying market gaps and opportunities for product innovation. Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape. Making informed...
    The Worldwide Market for Liquid Biopsy, 6th Edition

    Published: December 29, 2023 | Price: $5,000.00 – $10,000.00

    Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...
    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

    Published: November 29, 2023 | Price: $5,000.00 – $10,000.00

    In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare.  For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost.  While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...